Business Daily from THE HINDU group of publications
Wednesday, Dec 31, 2008
ePaper | Mobile/PDA Version | Audio | Blogs
Business Daily from THE HINDU group of publications Wednesday, Dec 31, 2008 ePaper | Mobile/PDA Version | Audio | Blogs |
|
|
|
|
|
Corporate
-
Regulatory Bodies & Rulings Aurobindo HIV drug gets FDA nod Hyderabad, Dec. 22 Aurobindo Pharma Ltd has received tentative approval for its New Drug Application (NDA) Abacavir Sulfate / Lamivudine tablets in 60/30 mg from the US Food and Drug Administration (US FDA). The NDA provides for the use of Abacavir Sulfate/ Lamivuudine for treating HIV infections. The Hyderabad-based company had also secured registration from the Medicines Control Council (MCC), South Africa, to manufacture and market four products. The products, which are under the Central Nervous System (CNS), are Auropidone, Auropidone (tablet and solution), Auro-Risperidone (solution) and AuroSumatriptan (tablet), the Hyderabad-based company said in a release. - Our BureauMore Stories on : Regulatory Bodies & Rulings | Pharmaceuticals
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
|
|
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |
Copyright © 2008, The
Hindu Business Line. Republication or redissemination of the contents of
this screen are expressly prohibited without the written consent of
The Hindu Business Line
|
